Hypertonic saline attenuation of polymorphonuclear neutrophil cytotoxicity: Timing is everything

Journal of Trauma - Injury, Infection and Critical Care

Volumn 48, Issue 3, 2000, Pages 388-395

  Ciesla, David J ^a   Moore, Ernest E ^a   Zallen, Garret ^a   Biffl, Walter L ^a   Silliman, Christopher C ^b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Elastase; Hypertonic saline; Integrin; Neutrophil; Respiratory burst; Resuscitation

Indexed keywords

CYTOCHROME C OXIDASE; ELASTASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTEGRIN; SODIUM CHLORIDE; SUPEROXIDE;

ATTENUATION; CONFERENCE PAPER; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST; RESUSCITATION;

EID: 0034070986     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-200003000-00004     Document Type: Conference Paper

References (44)

1. Mattox KL, Maningas PA, Moore EE, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension: the USA Multicenter Trial. Ann Surg. 1991; 213:482-491.
2. Vassar MJ, Fischer RP, O'Brien PE, et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg. 1993;128:1003-1011, discussion 1011-1013.
3. Wade CE, Grady JJ, Kramer GC, et al. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma. 1997;42(suppl 5):S61-S65.
4. Younes RN, Aun F, Ching CT, et al. Prognostic factors to predict outcome following the administration of hypertonic/ hyperoncotic solution in hypovolemic patients. Shock. 1997; 7:79-83.
5. Angle N, Hoyt DB, Cabello-Passini R, et al. Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. J Trauma. 1998;45:7-12, discussion 12-13.
6. Angle N, Hoyt DB, Coimbra R, et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock. 1998: 9:164-170.
7. Corso CO, Okamoto S, Leiderer R, Messmer K. Resuscitation with hypertonic saline dextran reduces endothelial cell swelling and improves hepatic microvascular perfusion and function after hemorrhagic shock. J Surg Res. 1998;80:210-220.
8. Corso CO, Okamoto S, Ruttinger D, Messmer K. Hypertonic saline dextran attenuates leukocyte accumulation in the liver after hemorrhagic shock and resuscitation. J Trauma. 1999;46:417-423.
9. Rizoli SB, Kapus A, Fan J, et al. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol. 1998;161:6288-6296.
10. Horton JW, White DJ, Hunt JL. Delayed hypertonic saline dextran administration after burn injury. J Trauma. 1995; 38:281-286.
11. Shackford SR. Hypertonic saline and dextran for intraoperative fluid therapy: more for less [editorial comment]. Crit Care Med. 1992;20:160-162.
12. Botha AJ, Moore FA, Moore EE, et al. Postinjury neutrophil priming and activation states: therapeutic challenges [editorial]. Shock. 1995;3:157-166.
13. Mukaida N, Matsumoto T, Yokoi K, et al. Inhibition of neutrophil-mediated acute inflammation injury by an antibody against interleukin-8 (IL-8). Inflamm Res. 1998; 47(suppl3):S151-S157.
14. Botha AJ, Moore FA, Moore EE, et al. Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma. 1995;39(3):411-417.
15. Partrick DA, Moore FA, Moore EE, et al. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz. 1996;4:194-210.
16. Windsor AC, Mullen PG, Fowler AA, Sugerman HJ. Role of the neutrophil in adult respiratory distress syndrome. Br J Surg. 1993;80:10-17.
17. Junger WG, Hoyt DB, Davis RE, et al. Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. J Clin Invest. 1998;101:2768-2779.
18. Rizoli SB, Kapus A, Parodo J, Rotstein OD. Hypertonicity prevents lipopolysaccharide-stimulated CD11b/CD18 expression in human neutrophils in vitro: role for p38 inhibition. J Trauma. 1999;46:794-798, discussion 798-799.
19. Takahashi K, Matsumoto T, Kubo S, et al. Influence of hyperosmotic environment comparable to the renal medulla upon membrane NADPH oxidase of human polymorphonuclear leukocytes. J. Urol. 1994;152(pt 1):1622-1625.
20. Friese RS, Rehring TF, Wollmering M, et al. Trauma primes cells [editorial]. Shock. 1994;1:388-394.
21. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995;75:257-277.
22. Botha AJ, Moore FA, Moore EE, et al. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery: 1995;118:358-364, discussion 364-365.
23. Partrick DA, Moore EE, Moore FA, et al. Lipid mediators up-regulate CD11b and prime for concordant superoxide and elastase release in human neutrophils. J Trauma. 1997; 43:297-302, discussion 302-303.
24. Stewart AG, Harris T, De Nichilo M, Lopez AF. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes. Immunology. 1991;72:206-212.
25. Vercellotti GM, Yin HQ, Gustafson KS, et al. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood. 1988;71:1100-1107.
26. Chudnofsky CR, Dronen SC, Syverud SA, et al. Intravenous fluid therapy in the prehospital management of hemorrhagic shock: improved outcome with hypertonic saline/6% Dextran 70 in a swine model. Am J Emerg Med. 1989;7:357-363.
27. Dubick MA, Wade CE. A review of the efficacy and safety of 7.5% NaCl/6% dextran 70 in experimental animals and in humans. J Trauma. 1994;36:323-330.
28. Holcroft JW, Vassar MJ, Perry CA, et al. Use of a 7.5% NaCl/6% dextran 70 solution in the resuscitation of injured patients in the emergency room. Prog Clin Biol Res. 1989; 299:331-338.
29. Holcroft JW, Vassar MJ, Perry CA, et al. Perspectives on clinical trials for hypertonic saline/dextran solutions for the treatment of traumatic shock. Braz J Med Biol Res. 1989; 22:291-293.
30. Krausz MM. Controversies in shock research: hypertonic resuscitation - pros and cons. Shock. 1995;3:69-72.
31. Shackford SR, Bourguignon PR, Wald SL, et al. Hypertonic saline resuscitation of patients with head injury: a prospective, randomized clinical trial. J Trauma. 1998; 44:50-58.
32. Wade CE, Hannon JP, Bossone CA, Hunt MM. Superiority of hypertonic saline/dextran over hypertonic saline during the first 30 minutes of resuscitation following hemorrhagic hypotension in conscious swine. Resuscitation. 1990;20:49-56.
33. Wade CE, Kramer GC, Grady JJ, et al. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery. 1997;122:609-616.
34. Younes RN, Aun F, Accioly CQ, et al. Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery. 1992;111:380-385.
35. Kramer GC, Perron PR, Lindsey DC, et al. Small-volume resuscitation with hypertonic saline dextran solution. Surgery. 1986;100:239-247.
36. Moon PF, Kramer GC. Hypertonic saline-dextran resuscitation from hemorrhagic shock induces transient mixed acidosis. Crit Care Med. 1995;23:323-331.
37. Kim FJ, Moore EE, Moore FA, et al. Reperfused gut elaborates PAF that chemoattracts and primes neutrophils. J Surg Res. 1995;58:636-640.
38. Koike K, Moore EE, Moore FA, et al. Gut phospholipase A2 mediates neutrophil priming and lung injury after mesenteric ischemia-reperfusion. Am J Physiol. 1995;268(pt 1):G397-G403.
39. Moore EE, Moore FA, Franciose RJ, et al. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma. 1994;37:881-887.
40. Schleiffenbaum B, Moser R, Patarroyo M, Fehr J. The cell surface glycoprotein Mac-1 (CD11b/CD18) mediates neutrophil adhesion and modulates degranulation independently of its quantitative cell surface expression. J Immunol. 1989;142:3537-3545.
41. Vedder NB, Harlan JM. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest. 1988;81:676-682.
42. Barnett CC Jr, Moore EE, Mierau GW, et al. ICAM-1-CD18 interaction mediates neutrophil cytotoxicity through protease release. Am J Physiol. 1998;274(pt 1):C1634-C1644.
43. Hampton MB, Chambers ST, Vissers MC, Winterbourn CC. Bacterial killing by neutrophils in hypertonic environments. J Infect Dis. 1994;169:839-846.
44. Patrick DA, Moore EE, Offner PJ, et al. Hypertonic saline activates lipid-primed human neutrophils for enhanced elastase release. J Trauma. 1998;44:592-597, discussion 598.